Genmab, Roche deal

Roche's Ventana Medical Systems Inc. unit partnered with Genmab to develop an immunohistochemistry (IHC) companion diagnostic for Genmab's HuMax-TF-ADC. The antibody-drug conjugate (ADC) against tissue factor is in a Phase I trial to treat solid tumors. Ventana said financials details are not disclosed. ...